Trial intelligence / Profile preview

Fentanyl versus dexmedetomidine as spinal adjuvants for post-cesarean pain

IRCT20211012052747N1Phase 3Completed

Sponsor
Vice Chancellor for Research, Birjand University of Medical Sciences
Start
Nov 2021
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of fentanyl, dexmedetomidine and bupivacaine in postoperative pain (2 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoint: Pain intensity. Started Nov 2021; status: completed.

02

Drugs

fentanyldexmedetomidinebupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20211012052747N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211012052747N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call